From Congress to Clinic: A Post-ESMO Breast Cancer 2021 Update on Immune-Based Therapies in Triple-Negative Breast Cancer

Get up to speed on immune-based therapies for triple-negative breast cancer including the most clinically relevant data from ESMO Breast Cancer 2021 with this on-demand webcast and downloadable slides from a live CCO webinar.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.